Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Isaacs

Showing results (441-450 of 743) with videos related to

Pageof 75
Sort By:
Clinical and Experimental Immunology|September 30, 2000
Local bioactive tumour necrosis factor (TNF) in corneal allotransplantationS A Rayner, W J King, R M Comer, et al.
Arthritis and Rheumatism|November 10, 2010
Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven lociDarren Plant, John Bowes, Catherine Potter, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative diseaseArthur G Pratt, Daniel C Swan, Sarah Richardson, et al.
Archives of Disease in Childhood|April 1, 1989
Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United KingdomG Tudor-Williams, J Frankland, D Isaacs, et al.
The Pharmacogenomics Journal|July 17, 2013
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJ Bluett, I Ibrahim, D Plant, et al.
Rheumatology (Oxford, England)|January 19, 2017
The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
Rheumatology (Oxford, England)|August 28, 2016
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levelsMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Blood|October 25, 2001
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cellsW F Ng, P J Duggan, F Ponchel, et al.
Archives of Disease in Childhood|August 1, 1988
Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is neededD Isaacs, E R Moxon, D Harvey, et al.
The Journal of Urology|August 28, 1998
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomyG S Bova, A W Partin, S D Isaacs, et al.
Pageof 75

Showing results (441-450 of 743) with videos related to

Sort By:
Pageof 75
Clinical and Experimental Immunology|September 30, 2000
Local bioactive tumour necrosis factor (TNF) in corneal allotransplantationS A Rayner, W J King, R M Comer, et al.
Arthritis and Rheumatism|November 10, 2010
Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven lociDarren Plant, John Bowes, Catherine Potter, et al.
Annals of the Rheumatic Diseases|April 26, 2012
A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative diseaseArthur G Pratt, Daniel C Swan, Sarah Richardson, et al.
Archives of Disease in Childhood|April 1, 1989
Haemophilus influenzae type b conjugate vaccine trial in Oxford: implications for the United KingdomG Tudor-Williams, J Frankland, D Isaacs, et al.
The Pharmacogenomics Journal|July 17, 2013
Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohortJ Bluett, I Ibrahim, D Plant, et al.
Rheumatology (Oxford, England)|January 19, 2017
The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohortSamantha Louise Smith, Darren Plant, Stephen Eyre, et al.
Rheumatology (Oxford, England)|August 28, 2016
Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levelsMeghna Jani, John D Isaacs, Ann W Morgan, et al.
Blood|October 25, 2001
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cellsW F Ng, P J Duggan, F Ponchel, et al.
Archives of Disease in Childhood|August 1, 1988
Ribavirin in respiratory syncytial virus infection. A double blind placebo controlled trial is neededD Isaacs, E R Moxon, D Harvey, et al.
The Journal of Urology|August 28, 1998
Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomyG S Bova, A W Partin, S D Isaacs, et al.
Pageof 75